Skip to main content
Erschienen in: Rheumatology International 7/2014

01.07.2014 | Short Communication

Monosodium glutamate and aspartame in perceived pain in fibromyalgia

verfasst von: María Y. Vellisca, José I. Latorre

Erschienen in: Rheumatology International | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Our aim was to assess the effect of dietary elimination of monosodium glutamate (MSG) and aspartame on perceived pain in fibromyalgia. A total of 72 female patients with fibromyalgia were randomized to discontinuation of dietary MSG and aspartame (n = 36) or waiting list (n = 36). Patients were requested to rate their pain using a seven-point scale. Comparisons between both groups showed no significant differences on pain referred during the baseline or after the elimination of dietary MSG and aspartame. The discontinuation of dietary MSG and aspartame did not improve the symptoms of fibromyalgia.
Literatur
1.
Zurück zum Zitat Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172PubMedCrossRef Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172PubMedCrossRef
2.
Zurück zum Zitat Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19–28PubMedCrossRef Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19–28PubMedCrossRef
3.
Zurück zum Zitat Carmona L, Ballina J, Gabriel R, Laffon A, EPISER Study Group (2001) The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis 60:1040–1045PubMedCentralPubMedCrossRef Carmona L, Ballina J, Gabriel R, Laffon A, EPISER Study Group (2001) The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis 60:1040–1045PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Goldenberg DL, Burckhardt C, Crofford L (2004) Management of fibromyalgia syndrome. JAMA 292:2388–2395PubMedCrossRef Goldenberg DL, Burckhardt C, Crofford L (2004) Management of fibromyalgia syndrome. JAMA 292:2388–2395PubMedCrossRef
5.
Zurück zum Zitat Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D et al (2008) EULAR evidence based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 67:536–541PubMedCrossRef Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D et al (2008) EULAR evidence based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 67:536–541PubMedCrossRef
6.
Zurück zum Zitat Smith JD, Terpening CM, Schmidt SO, Gums JG (2001) Relief of fibromyalgia symptoms following discontinuation of dietary excitotoxins. Ann Pharmacother 35:702–706PubMedCrossRef Smith JD, Terpening CM, Schmidt SO, Gums JG (2001) Relief of fibromyalgia symptoms following discontinuation of dietary excitotoxins. Ann Pharmacother 35:702–706PubMedCrossRef
7.
Zurück zum Zitat Ciappuccini R, Ansemant T, Maillefert JF, Tavernier C, Ornetti P (2010) Aspartame-induced fibromyalgia, an unusual but curable cause of chronic pain. Clin Exp Rheumatol 28:131–133 Ciappuccini R, Ansemant T, Maillefert JF, Tavernier C, Ornetti P (2010) Aspartame-induced fibromyalgia, an unusual but curable cause of chronic pain. Clin Exp Rheumatol 28:131–133
8.
Zurück zum Zitat Logan A (2003) Dietary modifications and fibromyalgia. Complement Health Pract Rev 8:234–245 Logan A (2003) Dietary modifications and fibromyalgia. Complement Health Pract Rev 8:234–245
Metadaten
Titel
Monosodium glutamate and aspartame in perceived pain in fibromyalgia
verfasst von
María Y. Vellisca
José I. Latorre
Publikationsdatum
01.07.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 7/2014
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2801-5

Weitere Artikel der Ausgabe 7/2014

Rheumatology International 7/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.